Kumar, S.; Principe, D.R.; Singh, S.K.; Viswakarma, N.; Sondarva, G.; Rana, B.; Rana, A.
Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer. Pharmaceuticals 2020, 13, 9.
https://doi.org/10.3390/ph13010009
AMA Style
Kumar S, Principe DR, Singh SK, Viswakarma N, Sondarva G, Rana B, Rana A.
Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer. Pharmaceuticals. 2020; 13(1):9.
https://doi.org/10.3390/ph13010009
Chicago/Turabian Style
Kumar, Sandeep, Daniel R. Principe, Sunil Kumar Singh, Navin Viswakarma, Gautam Sondarva, Basabi Rana, and Ajay Rana.
2020. "Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer" Pharmaceuticals 13, no. 1: 9.
https://doi.org/10.3390/ph13010009
APA Style
Kumar, S., Principe, D. R., Singh, S. K., Viswakarma, N., Sondarva, G., Rana, B., & Rana, A.
(2020). Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer. Pharmaceuticals, 13(1), 9.
https://doi.org/10.3390/ph13010009